Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLATO-3: Teicoplanin TDM-optimized Dosing vs Standard of Care
NCT05914467Phase 4Terminated
- Sponsor
- Radboud University Medical Center
- Start
- Aug 2023
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of teicoplanin in bacterial infection, sponsored by Radboud University Medical Center. Started Aug 2023; status: terminated.
02
Drugs
teicoplanin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT05914467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05914467.